1Caldes T,Iniesta P,Vega F J,et al.Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer[J].Oncology,1998,55(3):249.
2Liloglou T,Ross H,Prime W,et al.P53 gene aberrations in non-small-cell lung carcinomas from a smoking population[J].Br J Cancer,1997,75(8):1119.
3Li Z H,Zheng J,Weiss L M,et al.C-K-ras and P53 mutations occur very early in the adenocar cinoma of lung cancer[J].Am J Pathdol,1994,144(2):303.
6Liang J T,Cheng Y M,Chang K J,et al.Reappraisal of K-ras and p53 gene mutation in the recurrence of Dukes'BZ rectal cancer after curative resection[J].Hepatogastroenterology,1999,46(26):830.
5Yin L I,Marcia I.Reguoation of RARβexpression by RAR-and RXR-selective retinoids in human lung cancer cell lines:effect on growth inhibition and apoptosis induction[J].Int J Cancer,1998,75:88.
6Knudsen K E,Weber E,Arden K C,et al.The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms:inhibition of cell cycle progression and induction of cell death[J].Oncogene,1999,18(37):5239.
7Panigone S,Debermardi S,et al.Rb and Cdk regulation by N-(4-hydroxypheny) retinamide[J].Oncogene,2000,19(35):4035.
8Alesse E,Zazzeroni F,Angelucci A,et al.The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction,Rb underphosphorylation and E2F sequestering[J].Cell Death Differ,1998,5(5):381.
9Yap D B,Hesieh J K,Chan F S,et al.mdm2:a bridge over the two tumour suppressors,p53 and Rb[J].Oncogene,1999,18(53):7681.
10Barlogie B,Rber MN,Schman J,et al.Flow cytometry in clinical cancer reserch[J].CancerRes,1983,43:3 928-930.
